With desired results achieved, GlaxoSmithKline's first clinical trial is a success. The experimental Ebola vaccine will require further fine-tuning but it's definitely headed in the right direction.
With desired results achieved, GlaxoSmithKline's first clinical trial is a success. The experimental Ebola vaccine will require further fine-tuning but it's definitely headed in the right direction.
Share this Article
Recommended